C217 - Core Concepts in Pain Management: Refractory Neuropathic Pain Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids

Event Time: Thursday May 9, 2019 1:00 pm to 3:00 pm
Topic(s): Pain and Palliative Care
Director(s): James Watson MD
Description: Neuropathic pain is challenging to treat and frustrating to caregivers and patients when first line agents are insufficient. This session will be presented by a multidisciplinary faculty and focus on the treatment of refractory neuropathic pain. It is structured to be clinically relevant to non-pain specialists. Topics will include the role of non-first line neuropathic pain adjuvants, NMDA antagonists, topicals, opioids, and cognitive behavioral treatments. The evolving role of neuromodulation for refractory neuropathic pain with new technologies and target sites will be discussed. The accessibility of medical cannabinoids continues to grow. This session will also discuss the facts and fiction behind cannabinoids in the treatment of neuropathic pain.
Completion Message: Participants should be able to discuss strategies to mitigate the failure of first line neuropathic pain adjuvants, understand second line pharmacologic and topical treatments, and the role of opioids in neuropathic pain treatment. Participants will understand the expanding types and targets of neuromodulation and where they fit in the treatment algorithm. Participants will understand the facts and fiction behind the use of cannabinoids in the treatment of neuropathic pain.
CME Credits: 2
Core Competencies: Patient Care

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses